Literature DB >> 19997776

Brain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson disease.

Ho-Joo Lee1, Richard P Bazinet, Stanley I Rapoport, Abesh Kumar Bhattacharjee.   

Abstract

Arachidonic acid (AA) signaling is upregulated in the caudate-putamen and frontal cortex of unilaterally 6-hydroxydopamine (6-OHDA) lesioned rats, a model for asymmetrical Parkinson disease. AA signaling can be coupled to D(2)-like receptor initiated AA hydrolysis from phospholipids by cytosolic phospholipase A(2) (cPLA(2)) and subsequent metabolism by cyclooxygenase (COX)-2. In unilaterally 6-OHDA- and sham-lesioned rats, we measured brain expression of cPLA(2), other PLA(2) enzymes, and COX-2. Activity and protein levels of cPLA(2) were significantly higher as was COX-2-protein in caudate-putamen, frontal cortex and remaining brain on the lesioned compared to intact side of the 6-OHDA lesioned rats, and compared to sham brain. Secretory sPLA(2) and Ca(2+)-independent iPLA(2) expression did not differ between sides or groups. Thus, the tonically increased ipsilateral AA signal in the lesioned rat corresponds to upregulated cPLA(2) and COX-2 expression within the AA metabolic cascade, which may contribute to symptoms and pathology in Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19997776      PMCID: PMC2836388          DOI: 10.1007/s11064-009-0106-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  72 in total

1.  The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease.

Authors:  B Mirza; H Hadberg; P Thomsen; T Moos
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Distribution of cytoplasmic phospholipase A2 in the normal rat brain.

Authors:  W Y Ong; T L Sandhya; L A Horrocks; A A Farooqui
Journal:  J Hirnforsch       Date:  1999

Review 3.  Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction.

Authors:  J Axelrod
Journal:  Biochem Soc Trans       Date:  1990-08       Impact factor: 5.407

4.  Alpha-1 adrenergic receptor mediates the release of arachidonic acid in spinal cord neurons independent of phosphatidylinositol-specific phospholipase C.

Authors:  R Y Kanterman; J Axelrod; C C Felder
Journal:  Adv Second Messenger Phosphoprotein Res       Date:  1990

5.  Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat.

Authors:  W C Graham; A R Crossman; G N Woodruff
Journal:  Brain Res       Date:  1990-04-23       Impact factor: 3.252

Review 6.  Arachidonic acid cascade and signal transduction.

Authors:  T Shimizu; L S Wolfe
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

7.  Imbalance of brain monoamines and clinical disorders.

Authors:  O Hornykiewicz
Journal:  Prog Brain Res       Date:  1982       Impact factor: 2.453

8.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.

Authors:  C R Gerfen; T M Engber; L C Mahan; Z Susel; T N Chase; F J Monsma; D R Sibley
Journal:  Science       Date:  1990-12-07       Impact factor: 47.728

9.  Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats.

Authors:  J Arnt; J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP.

Authors:  J D Clark; L L Lin; R W Kriz; C S Ramesha; L A Sultzman; A Y Lin; N Milona; J L Knopf
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

View more
  12 in total

Review 1.  Role of cytosolic calcium-dependent phospholipase A2 in Alzheimer's disease pathogenesis.

Authors:  M T Gentile; M G Reccia; P P Sorrentino; E Vitale; G Sorrentino; A A Puca; L Colucci-D'Amato
Journal:  Mol Neurobiol       Date:  2012-05-31       Impact factor: 5.590

2.  Evaluation of antiparkinson activity of PTUPB by measuring dopamine and its metabolites in Drosophila melanogaster: LC-MS/MS method development.

Authors:  Navya Lakkappa; Praveen T Krishnamurthy; Karthik Yamjala; Sung Hee Hwang; Bruce D Hammock; B Babu
Journal:  J Pharm Biomed Anal       Date:  2017-11-16       Impact factor: 3.935

Review 3.  Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

Authors:  Mireille Basselin; Epolia Ramadan; Stanley I Rapoport
Journal:  Brain Res Bull       Date:  2011-12-09       Impact factor: 4.077

4.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

5.  Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders.

Authors:  Navya Lakkappa; Praveen T Krishnamurthy; Bruce D Hammock; D Velmurugan; M M Srinivas Bharath
Journal:  Med Hypotheses       Date:  2016-06-05       Impact factor: 1.538

6.  Expression of mutant alpha-synuclein modulates microglial phenotype in vitro.

Authors:  Lalida Rojanathammanee; Eric J Murphy; Colin K Combs
Journal:  J Neuroinflammation       Date:  2011-05-09       Impact factor: 8.322

7.  Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease.

Authors:  Kyle Farmer; Catherine A Smith; Shawn Hayley; Jeffrey Smith
Journal:  Int J Mol Sci       Date:  2015-08-12       Impact factor: 5.923

8.  Apolipoprotein D Concentration in Human Plasma during Aging and in Parkinson's Disease: A Cross-Sectional Study.

Authors:  Andreas Waldner; Sarah Dassati; Bernhard Redl; Nicola Smania; Marialuisa Gandolfi
Journal:  Parkinsons Dis       Date:  2018-03-26

9.  Metabolomic investigations in cerebrospinal fluid of Parkinson's disease.

Authors:  Desiree Willkommen; Marianna Lucio; Franco Moritz; Sara Forcisi; Basem Kanawati; Kirill S Smirnov; Michael Schroeter; Ali Sigaroudi; Philippe Schmitt-Kopplin; Bernhard Michalke
Journal:  PLoS One       Date:  2018-12-10       Impact factor: 3.240

Review 10.  The Role of Lipids in Parkinson's Disease.

Authors:  Helena Xicoy; Bé Wieringa; Gerard J M Martens
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.